BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16396150)

  • 1. Novel agents in first-line therapy for myeloma.
    Jagannath S
    Oncology (Williston Park); 2005 Nov; 19(12):1551-4. PubMed ID: 16396150
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy-resistant leg ulcer caused by multiple myeloma.
    Bago A; Schweiter J; Kiss M; Furesz J; Vajda A; Balo-Banga JM
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):647-8. PubMed ID: 16164734
    [No Abstract]   [Full Text] [Related]  

  • 3. Two cases of plasma cell leukemia with atypical immunophenotype.
    Buda G; Carulli G; Orciuolo E; Cannizzo E; Zucca A; Azzarà A; Rossi A; Galimberti S; Cecconi N; Petrini M
    Acta Haematol; 2007; 118(1):27-9. PubMed ID: 17429194
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines on the diagnosis and management of multiple myeloma 2005.
    Smith A; Wisloff F; Samson D; ; ;
    Br J Haematol; 2006 Feb; 132(4):410-51. PubMed ID: 16412016
    [No Abstract]   [Full Text] [Related]  

  • 5. Myeloma bone disease: pathogenesis and treatment.
    Roodman GD;
    Oncology (Williston Park); 2005 Jul; 19(8):983-4, 986. PubMed ID: 16131042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Meningeal plasmacytoma: delayed diagnosis with sequelae].
    Buchbender C; Antoch G; Nawatny J
    Rofo; 2011 Aug; 183(8):761-2. PubMed ID: 21442568
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fatal complications of long-term immunosuppressive therapy in a renal transplant recipient].
    Rekhtina IG; Biriukova LS
    Ter Arkh; 2008; 80(7):62-4. PubMed ID: 18763600
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
    Huston A; Brown J; Roodman GD
    Exp Hematol; 2006 Dec; 34(12):1616. PubMed ID: 17157156
    [No Abstract]   [Full Text] [Related]  

  • 9. Amyloid deposition of systemic myeloma-associated amyloidosis excludes actinic elastotic material.
    Wada N; Fujimoto N; Komatsu T; Tajima S; Ishibashi A
    Eur J Dermatol; 2002; 12(6):607-8. PubMed ID: 12459542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma in the era of novel agents.
    Dimopoulos MA; Attal M
    Semin Hematol; 2009 Apr; 46(2):107-9. PubMed ID: 19389493
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-secretory multiple myeloma with hypercalcemic acute renal failure.
    Prakash MS; Baliga KV; Singh AP; Mishra DK
    J Assoc Physicians India; 2002 Oct; 50():1330-1. PubMed ID: 12568228
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple myeloma.
    Bhattacharya SK; Singh NK; Srivastava PK; Tripathi K; Somani PN
    J Indian Med Assoc; 1984 Nov; 82(11):394-7. PubMed ID: 6535796
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multiple myeloma -- case report].
    Zettl F; Jung W; Schroers R
    Dtsch Med Wochenschr; 2005 Feb; 130(6):277; quiz 287-90. PubMed ID: 15692901
    [No Abstract]   [Full Text] [Related]  

  • 14. Infiltration of the spinal cord in a patient with multiple myeloma.
    Varettoni M; Corso A; Zappasodi P; Calliada F; Castagnola C; Mangiacavalli S; Lazzarino M
    J Clin Oncol; 2008 Sep; 26(25):4207-9. PubMed ID: 18757337
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute tubulo-interstitiel nephritis associated with diffuse large B-cell lymphoma presenting as acute renal failure.
    Dede F; Yilmaz B; Ayli D; Kayataş M; Atilgan G; Caner S; Akyürek N; Odabaş AR
    Ren Fail; 2008; 30(4):465-7. PubMed ID: 18569923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid fistula associated with an empty sella.
    Palacios E; Rojas R; Restrepo S
    Ear Nose Throat J; 2002 Nov; 81(11):764-5. PubMed ID: 12472026
    [No Abstract]   [Full Text] [Related]  

  • 17. Bortezomib in relapsed multiple myeloma complicated by extramedullary plasmacytomas.
    Hughes M; Micallef-Eynaud P
    Clin Lab Haematol; 2006 Aug; 28(4):267-9. PubMed ID: 16898968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloma update.
    Mulligan ME
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):231-9. PubMed ID: 18260033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II trial assessing bortezomib and melphalan combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.
    Berenson JR; Yang HH; Sadler K; Jarutirasarn SG; Vescio RA; Mapes R; Purner M; Lee SP; Wilson J; Morrison B; Adams J; Schenkein D; Swift R
    J Clin Oncol; 2006 Feb; 24(6):937-44. PubMed ID: 16418495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple eruptive dermatofibromas and immunosuppression: report of two cases and review of the literature.
    Zaccaria E; Rebora A; Rongioletti F
    Int J Dermatol; 2008 Jul; 47(7):723-7. PubMed ID: 18613883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.